These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 8281664)

  • 21. The effects of insulin-like growth factor-1 on plasminogen activator inhibitor-1 synthesis and secretion: results from in vitro and in vivo studies.
    Padayatty SJ; Orme S; Zenobi PD; Stickland MH; Belchetz PE; Grant PJ
    Thromb Haemost; 1993 Dec; 70(6):1009-13. PubMed ID: 8165592
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased expression of plasminogen activator inhibitor type-1 (PAI-1) in HEPG2 cells induced by insulin mediated by the 3'-untranslated region of the PAI-1 gene and its pharmacologic implications.
    Miyagawa R; Asakura T; Nakamura T; Okada H; Iwaki S; Sobel BE; Fujii S
    Coron Artery Dis; 2010 May; 21(3):144-50. PubMed ID: 20299979
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determinants of plasminogen activator inhibitor-1 activity in survivors of myocardial infarction.
    Gray RP; Mohamed-Ali V; Patterson DL; Yudkin JS
    Thromb Haemost; 1995 Feb; 73(2):261-7. PubMed ID: 7792741
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of statins on modulation by insulin of expression of plasminogen activator inhibitor type-1.
    Sato Y; Dong J; Imagawa S; Ishimori N; Furumoto T; Tsutsui H; Sobel BE; Fujii S
    Coron Artery Dis; 2008 Aug; 19(5):355-61. PubMed ID: 18607173
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasminogen activator inhibitor-1 in nonobese subjects with non-insulin-dependent diabetes mellitus.
    Ito Y; Okeda T; Sato Y; Ito M; Sakata T
    Proc Soc Exp Biol Med; 1996 Mar; 211(3):287-91. PubMed ID: 8633110
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of synthesis of plasminogen activator inhibitor type-1 by tissue-type plasminogen activator in human hepatic and endothelial cells.
    Fujii S; Lucore CL; Hopkins WE; Billadello JJ; Sobel BE
    Thromb Haemost; 1990 Nov; 64(3):412-9. PubMed ID: 2128971
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of endothelial cell expression of plasminogen activator inhibitor type-1 by gemfibrozil.
    Fujii S; Sawa H; Sobel BE
    Thromb Haemost; 1993 Oct; 70(4):642-7. PubMed ID: 7509512
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Up-regulated expression of plasminogen activator inhibitor-1 in Hep G2 cells: interrelationship between insulin and insulin-like growth factor 1.
    Anfosso F; Alessi MC; Nalbone G; Chomiki N; Henry M; Juhan-Vague I
    Thromb Haemost; 1995 Feb; 73(2):268-74. PubMed ID: 7792742
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiotensin II increases plasminogen activator inhibitor type 1 and tissue-type plasminogen activator messenger RNA in cultured rat aortic smooth muscle cells.
    van Leeuwen RT; Kol A; Andreotti F; Kluft C; Maseri A; Sperti G
    Circulation; 1994 Jul; 90(1):362-8. PubMed ID: 8026020
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diminished fibrinolysis in diabetes mellitus and its implication for diabetic vascular disease.
    Panahloo A; Yudkin JS
    Coron Artery Dis; 1996 Oct; 7(10):723-31. PubMed ID: 8970763
    [No Abstract]   [Full Text] [Related]  

  • 31. Hyperglycaemic siblings of Type II (non-insulin-dependent) diabetic patients have increased PAI-1, central obesity and insulin resistance compared with their paired normoglycaemic sibling.
    Herlihy OM; Barrow BA; Grant PJ; Levy JC
    Diabetologia; 2002 May; 45(5):635-41. PubMed ID: 12107743
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors responsible for impaired fibrinolysis in obese subjects and NIDDM patients.
    McGill JB; Schneider DJ; Arfken CL; Lucore CL; Sobel BE
    Diabetes; 1994 Jan; 43(1):104-9. PubMed ID: 8262307
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasminogen activator inhibitor type-1 synthesis and mRNA expression in HepG2 cells are regulated by VLDL.
    Sironi L; Mussoni L; Prati L; Baldassarre D; Camera M; Banfi C; Tremoli E
    Arterioscler Thromb Vasc Biol; 1996 Jan; 16(1):89-96. PubMed ID: 8548432
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential regulation by troglitazone of plasminogen activator inhibitor type 1 in human hepatic and vascular cells.
    Nordt TK; Peter K; Bode C; Sobel BE
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1563-8. PubMed ID: 10770198
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Augmentation of synthesis of plasminogen activator inhibitor type 1 by insulin and insulin-like growth factor type I: implications for vascular disease in hyperinsulinemic states.
    Schneider DJ; Sobel BE
    Proc Natl Acad Sci U S A; 1991 Nov; 88(22):9959-63. PubMed ID: 1719559
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prolactin regulation of tissue type plasminogen activator and plasminogen activator inhibitor type-I gene expression in eCG-primed rat granulosa cells in culture.
    Liu YX; Peng XR; Liu HZ; Chen YJ; Ny T
    Biol Reprod; 1998 Aug; 59(2):409-16. PubMed ID: 9687315
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glucocorticoids and insulin promote plasminogen activator inhibitor 1 production by human adipose tissue.
    Morange PE; Aubert J; Peiretti F; Lijnen HR; Vague P; Verdier M; Négrel R; Juhan-Vague I; Alessi MC
    Diabetes; 1999 Apr; 48(4):890-5. PubMed ID: 10102708
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stimulated in vivo synthesis of plasminogen activator inhibitor-1 in human adipose tissue.
    Ekström M; Liska J; Eriksson P; Sverremark-Ekström E; Tornvall P
    Thromb Haemost; 2012 Sep; 108(3):485-92. PubMed ID: 22740034
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor necrosis factor-alpha-induced production of plasminogen activator inhibitor 1 and its regulation by pioglitazone and cerivastatin in a nonmalignant human hepatocyte cell line.
    Takeshita Y; Takamura T; Hamaguchi E; Shimizu A; Ota T; Sakurai M; Kaneko S
    Metabolism; 2006 Nov; 55(11):1464-72. PubMed ID: 17046548
    [TBL] [Abstract][Full Text] [Related]  

  • 40. C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: implications for the metabolic syndrome and atherothrombosis.
    Devaraj S; Xu DY; Jialal I
    Circulation; 2003 Jan; 107(3):398-404. PubMed ID: 12551862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.